PubMed Health⌕ Search

Biomedical subjects

D F Neri

Publications and source records attributed to D F Neri.

16 recordsLinked to original sources
PubMed2001

Microgravity reduces sleep-disordered breathing in humans.

To understand the factors that alter sleep quality in space, we studied the effect of spaceflight on sleep-disordered breathing. We analyzed 77 8-h, full polysomnographic recordings (PSGs) from five healthy subjects before spaceflight, on four occasions per subject during either a 16- or 9-d space shuttle mission and shortly after return to earth. Microgravity was associated with a 55% reduction in the apnea-hypopnea index (AHI), which decreased from a preflight value of 8.3 +/- 1.6 to 3.4 +/- 0.8 events/h inflight. This reduction in AHI was accompanied by a virtual elimination of snoring, which fell from 16.5 +/- 3.0% of total sleep time preflight to 0.7 +/- 0.5% inflight. Electroencephalogram (EEG) arousals also decreased in microgravity (by 19%), and this decrease was almost entirely a consequence of the reduction in respiratory-related arousals, which fell from 5.5 +/- 1.2 arousals/h preflight to 1.8 +/- 0.6 inflight. Postflight there was a return to near or slightly above preflight levels in these variables. We conclude that sleep quality during spaceflight is not degraded by sleep-disordered breathing. This is the first direct demonstration that gravity plays a dominant role in the generation of apneas, hypopneas, and snoring in healthy subjects.

Adult↗
PubMed2001

Sleep, performance, circadian rhythms, and light-dark cycles during two space shuttle flights.

Sleep, circadian rhythm, and neurobehavioral performance measures were obtained in five astronauts before, during, and after 16-day or 10-day space missions. In space, scheduled rest-activity cycles were 20-35 min shorter than 24 h. Light-dark cycles were highly variable on the flight deck, and daytime illuminances in other compartments of the spacecraft were very low (5.0-79.4 lx). In space, the amplitude of the body temperature rhythm was reduced and the circadian rhythm of urinary cortisol appeared misaligned relative to the imposed non-24-h sleep-wake schedule. Neurobehavioral performance decrements were observed. Sleep duration, assessed by questionnaires and actigraphy, was only approximately 6.5 h/day. Subjective sleep quality diminished. Polysomnography revealed more wakefulness and less slow-wave sleep during the final third of sleep episodes. Administration of melatonin (0.3 mg) on alternate nights did not improve sleep. After return to earth, rapid eye movement (REM) sleep was markedly increased. Crewmembers on these flights experienced circadian rhythm disturbances, sleep loss, decrements in neurobehavioral performance, and postflight changes in REM sleep.

Activity Cycles↗
PubMed1999

Nonentrained circadian rhythms of melatonin in submariners scheduled to an 18-hour day.

The human circadian timing system has previously been shown to free run with a period slightly longer than 24 h in subjects living in the laboratory under conditions of forced desynchrony. In forced desynchrony, subjects are shielded from bright light and periodic time cues and are required to live on a day length outside the range of circadian entrainment. The work schedule used for most personnel aboard American submarines is 6 h on duty alternating with 12 h off duty. This imposed 18-h cycle is too short for human circadian synchronization, especially given that there is no bright-light exposure aboard submarines. However, crew members are exposed to 24-h stimuli that could mediate synchronization, such as clocks and social contacts with personnel who are living on a 24-h schedule. The authors investigated circadian rhythms of salivary melatonin in 20 crew members during a prolonged voyage on a Trident nuclear submarine. The authors found that in crew members living on the 18-h duty cycle, the endogenous rhythm of melatonin showed an average period of 24.35 h (n = 12, SD = 0.18 h). These data indicate that social contacts and knowledge of clock time are insufficient for entrainment to a 24-h period in personnel living by an 18-h rest-activity cycle aboard a submarine.

Adult↗
PubMed1996

Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man.

Stimulants, in particular the amphetamines, have been studied as countermeasures to fatigue induced by circadian desynchronosis and extended flight operations. To make recommendations concerning the use of dextromethamphetamine for operational tasks, its chronopharmacokinetic and chronopharmacodynamic profiles and influence on circadian rhythms as a countermeasure to performance deficits and fatigue were studied. Ten male volunteers, divided into two groups of five each, were given 30 mg/70 kg of oral dextromethamphetamine during two test sessions one week apart and were evaluated with cognitive (dichotic listening, pattern recognition, and compensatory tracking), subjective (fatigue scale), and physiologic (blood pressure) testing. Session order was counterbalanced with dextromethamphetamine administration at either 8:40 AM or 8:40 PM during session one and a crossover to the other time during session two. Subjective and cognitive testing was begun 1.5 hours before dextromethamphetamine administration and continued every half hour until 12.5 hours after administration. Blood pressure was measured immediately before behavioral testing. Serum and urine were collected at regular intervals for gas chromatography/mass spectrometer analysis of methamphetamine and one of its metabolites, amphetamine. No differences were found in the day-versus-night pharmacokinetic profile of dextromethamphetamine. Cognitive performance and subjective fatigue improved after daytime administration of dextromethamphetamine in comparison to performance before drug administration. This effect was suppressed during the circadian trough, which occurred approximately 8 hours into the night sessions (4:30 AM). No correlations were seen between serum concentration of methamphetamine and measured behavioral parameters.

Adult↗
PubMed1996

Methamphetamine effects on cognitive processing during extended wakefulness.

We examined the effects of both 5- and 10-mg/7O kg body weight of d-methamphetamine HCl on high event rate vigilance and tracking performance in a 13.5-hr sustained-performance session during one night of sleep loss. At 0116 hours participants were administered either a 5 mg/70 kg oral dose of d-methamphetamine (n=10), 10 mg/70 kg d-methamphetamine (n=10), or a placebo (n=10) using standard double-blind procedures. Performance on all measures degraded markedly during the night in the placebo group. Both the 5- and 10-mg methamphetamines treatment reversed an initial decline in d', and reversed increases in nonresponses (lapses) and tracking error within approximately 3 hr of administration. No evidence that amphetamine treatment increased impulsive responding (fast guesses) was observed. The magnitude of the performance effects of the methamphetamine treatments was similar at 3 hr postadministration. However, the effects of the 5-mg dose were shorter-lived, disappearing by the last testing session (6.5 hr postadministration), whereas effects of the 10-mg dose tended to remain throughout testing. Both amphetamine treatments decreased subjective sleepiness during the night and tended to increase subjective sleep latencies during a post-testing sleep period.

Adult↗
PubMed1995

The effects of tyrosine on cognitive performance during extended wakefulness.

Tyrosine, a large neutral amino acid found in dietary proteins, has received recent attention as a potential treatment for stress. The behavioral effects of tyrosine were examined during an episode of continuous nighttime work involving one night's sleep loss. Subjects performed nine iterations of a battery of performance tasks and mood scales for approximately 13 h, beginning at 1930 and ending at 0820. They remained awake throughout the day on which the experiment began and were awake for more than 24 h by the end of testing. Six hours after the experiment began, one-half of the subjects received 150 mg.kg-1 tyrosine in a split dose while the other half received cornstarch placebo in a double-blind procedure. Tyrosine administration was associated with a significant amelioration of the usual performance decline on a psychomotor task and a significant reduction in lapse probability on a high-event-rate vigilance task. The improvements lasted on the order of 3 h. The results of this study also suggest that tyrosine is a relatively benign treatment at this dose. After further testing with other doses and timing of administration, tyrosine may prove useful in counteracting performance decrements during episodes of sustained work coupled with sleep loss.

Adult↗
PubMed1992

Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations.

We review the biochemistry and physiological role of the amino acid tyrosine in normal and stressful situations such as military sustained operations. Sustained operations consist of continuous work periods exceeding 12 h and often involve sleep loss and fatigue. These, in turn, can lead to stress, anxiety, mood deterioration, and performance decrement. Experimental data in the literature suggest that tyrosine, a precursor of the neurotransmitter norepinephrine, may be useful in counteracting any stress-related performance decrement and mood deterioration in the following way. First, various forms of stress induce brain depletion of catecholamines, especially norepinephrine, in animals. Second, brain norepinephrine levels are closely related to stress-induced performance decrement in animals. Third, the administration of tyrosine may minimize or reverse stress-induced performance decrement by increasing depleted brain norepinephrine levels. The types of performance degradation expected in military sustained operations and the potential physiological role tyrosine might play in improving mood and performance are discussed.

Attention↗
PubMed1991

Effect of extraneous targets on identification of color-coded targets.

Subjects matched the color of a vertical target line, presented in 1 of 10 colors, to a set of 10 colors. The target line was presented either in isolation or together with 5 additional colored lines. Neither mean reaction time nor the number of matching errors increased when the extraneous lines were present, and the types of color confusions did not change systematically.

Aerospace Medicine↗
PubMed1990

Color CRT characterization presented solely in terms of the CIE system.

Color CRT characterization provides a convenient means of producing colors specified in terms of their chromaticity coordinates and luminances. It also simplifies the inverse procedure by enabling the determination of the chromaticities and luminances of displayed colors without direct measurement. This paper presents the characterization procedure entirely within the context of the well-known CIE system, a brief description of which is provided as background. This presentation is intended for those with access to a spectral radiometer but little familiarity with color specification or measurement.

Attention↗
PubMed1986

The detection of various color combinations under different chromatic ambient illuminations.

Our purpose was to reveal the effects of ambient illumination color and various foreground/background color pairings on a choice reaction time task performed on a color CRT. Six men and two women with normal color vision served as observers in a four-alternative forced choice procedure. A small (18' visual angle) colored circle appeared in the center of one of the unmarked quadrants of the screen. The observer's task was to respond as quickly as possible to this target by pressing one of four buttons corresponding to its location. We found that target colors that were opponent to the background colors were most quickly detected. Detection was enhanced by maximizing both brightness and chromatic contrast, but brightness contrast was much more effective. Chromatic ambient lighting which was a log unit dimmer than the target luminance had no effect on performance.

Choice Behavior↗
PubMed1983

The perception of depth contours with yellow goggles.

The ability of subjects to discriminate the depth of depressions in the snow was conducted at a cross-country ski area. The percentage of correct judgments on an overcast day was significantly greater with yellow goggles than with luminance-matched neutral goggles. This experiment, suggested by the chromatic-achromatic theory of color vision, indicates why yellow goggles are popular despite many previous unsuccessful attempts to prove their effectiveness.

Color Perception↗
PubMed1983

Reaction time to spatial frequencies using yellow and luminance-matched neutral goggles.

The popularity of yellow goggles for outdoor activities has long been a paradox to visual scientists as previous tests of their effectiveness have failed to show any visual advantage. The achromatic/chromatic theory of color vision suggests a possible solution to the paradox which was tested by measuring reaction times to spatial frequencies of varying contrast. Reaction times were faster with yellow goggles than with luminance-matched neutrals under certain conditions. These conditions included frequencies in the middle of the range of human sensitivity and, specifically, the lower contrasts of these frequencies. The theoretical and practical applications of the results are discussed.

Color Perception↗
PubMed1983

Protection from light-rays by cold-weather goggles.

To arrive at transmittance standards for cold-weather goggles, the levels of natural radiation were estimated, and the amounts by which they must be reduced to fall below the damage thresholds for various bands of electromagnetic radiation were calculated. No more than 16% of UV from 320 to 40 nm, and no more than 5% of UV from 290 to 320 nm should be transmitted. If the short wavelengths of the visible spectrum (less than 500 nm) are filtered out, the remaining wavelengths appear to pose no danger. Measurements of the transmittances of a random selection of 13 commercial skigoggles showed that most offer satisfactory protection.

Altitude↗
PubMedDate not supplied

GC-MS determination of amphetamine and methamphetamine in human urine for 12 hours following oral administration of dextro-methamphetamine: lack of evidence supporting the established forensic guidelines for methamphetamine confirmation.

Ten human volunteers, naive to amphetamines and divided into two groups of five each, were given an oral dose of 30 mg/70 kg D-methamphetamine in one of two different paradigms: the initial dose at 0930 h or the initial dose at 2130 h. One week later, each subject was crossed over with regard to time but given the same dose. A total of 214 urine specimens were collected either prior to dosing or at each micturition for a 12-h period post dose. Specimens were analyzed on a blind basis for methamphetamine and one of its metabolites, amphetamine, by gas chromatography-mass spectrometry (GC-MS) using coinjection of extracted sample and pentafluoropropionic anhydride and selected-ion monitoring. Approximately 20% of the D-methamphetamine was recovered unchanged from the urine specimens, and 2% was recovered as amphetamine. The mean urine methamphetamine concentration in both groups reached a maximum within 4-6 h and declined thereafter. A residual amount of methamphetamine was found in some predose specimens at the crossover evaluation, reflecting that methamphetamine may be detected in urine for up to 7 days. The amphetamine concentration reached a plateau by 4-6 h. This observation coupled with the finding that all subjects excreted approximately 2% of the methamphetamine dose as amphetamine suggested a saturable process for its biotransformation. Concentrations of both methamphetamine and amphetamine tended to be higher, but were not significantly different, for night administration. Methamphetamine concentrations were consistently greater than the 500-ng/mL cutoff in most post-dosing specimens, whereas amphetamine concentrations generally did not achieve the 200-ng/mL cutoff specified by the Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines for GC-MS confirmation of methamphetamine. Some specimens containing methamphetamine had no amphetamine metabolite. The current guidelines would have resulted in 90.2% of the specimens containing methamphetamine being ruled negative by confirmation following either night or day administration, whereas one subject following the initial day administration and another following night crossover administration would have been judged positive at most time intervals. These findings suggest that the current SAMHSA guidelines select for individual metabolic variations and that GC-MS confirmation of methamphetamine will result in most occasional users being ruled negative following an oral dose of methamphetamine while some will be ruled positive.

Administration, Oral↗